piretanide has been researched along with Anemia, Sickle Cell in 1 studies
piretanide: potent inhibitor of chloride transport; structure
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Hb SC disease were found to have microcytic and hyperchromic red cell indices despite mild reticulocytosis." | 1.27 | The xerocytosis of Hb SC disease. ( Ballas, SK; Larner, J; Rappaport, EF; Schwartz, E; Smith, ED; Surrey, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballas, SK | 1 |
| Larner, J | 1 |
| Smith, ED | 1 |
| Surrey, S | 1 |
| Schwartz, E | 1 |
| Rappaport, EF | 1 |
1 other study available for piretanide and Anemia, Sickle Cell
| Article | Year |
|---|---|
The xerocytosis of Hb SC disease.
Topics: Adenosine Triphosphatases; Anemia, Sickle Cell; Erythrocyte Deformability; Erythrocyte Membrane; Ery | 1987 |